An anti-tumorigenic role for IL-33 in lung cancer was proposed in studies showing that male patients who had a history of smoking had significantly lower plasma IL-33 levels as compared to healthy controls and that IL-33 expression was inversely associated with progression of lung cancer [95]. The gene discussed is IL33; the disease is lung carcinoma.